Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
129Xe Gas Exchange MRI in Interstitial Lung Disease
NCT04855305Phase 2Completed
- Start
- Nov 2021
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hyperpolarized xenon gas in interstitial lung disease (ILD). Started Nov 2021; status: completed.
02
Drugs
hyperpolarized xenon gas
03
Conditions
interstitial lung disease (ILD)
Beyond the preview
Go deeper on NCT04855305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04855305.